The World In A Grain Of Sand

The World in a Grain of Sand: Schrödinger

Listen Later

KdT Ventures presents The World in a Grain of Sand, where we break down an S1 from a recent biotech IPO and share insights on the science, business models, and financials. In this episode, Patrick Malone and Mack Healy discuss the biopharma software juggernaut, Schrödinger. We dive into:

  • Schrödinger's biophysics-based drug discovery platform, and the distinction from machine learning approaches
  • A dissection of Schrödinger's software business, as well as co-development partnerships and internal therapeutic programs
  • The story of Schrödinger collaboration with Nimbus on a TYK2 program, resulting in a $4B+ acquisition by Takeda
  • and more

    • For updates from KdT, please subscribe to our Substack.

    Show Notes:

    • Takeda Acquires Nimbus’ Tyk2 Autoimmune Program
    • Discovering Nimbus
    • Selective TYK2 Inhibition: A Story of Vision and Perseverance
      • ...more
      View all episodesView all episodes
      Download on the App Store
      The World In A Grain Of SandBy KdT Ventures
      • 5
      • 5
      • 5
      • 5
      • 5

      5

      20 ratings